Home » Authors » Anette Breindl

Articles by Anette Breindl

Double Twist Limits Thyroid Receptor Agonist To Liver

Sep. 19, 2007

By Anette Breindl

Enrichment Pulls Naïve T-Cell Needle Out Of Lymph Haystack

Sep. 17, 2007

By Anette Breindl

Enrichment Pulls Naïve T-Cell Needle Out Of Lymph Haystack

Sep. 17, 2007

By Anette Breindl

More Is More For Receptor Tyrosine Kinase Inhibitors

Sep. 14, 2007

By Anette Breindl

More Is More For Receptor Tyrosine Kinase Inhibitors

Sep. 14, 2007

By Anette Breindl

Point Intervention Turns RTK Ligand From On To Off Switch

Sep. 13, 2007

By Anette Breindl

Point Intervention Turns RTK Ligand From On To Off Switch

Sep. 13, 2007

By Anette Breindl

Cancer Roles, miRNA Kinship Of Ultraconserved Regions

Sep. 11, 2007

By Anette Breindl

Cancer Roles, miRNA Kinship Of Ultraconserved Regions

Sep. 11, 2007

By Anette Breindl

Faster Knockout Identification By Building A Better Haystack

Sep. 7, 2007

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...